Responses

Download PDFPDF
Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Genetic susceptibility testing to lung cancer and outcomes for smokers

    NOT PEER REVIEWED We wish to comment on the findings of Smerecnik et al.1 with respect to significant advances in genetic testing , which are highly relevant to their review. Unlike the early single genetic marker tests analysed by Smerecnik et al.,1 where subjects are dichotomised to positive or negative results, genetic susceptibility tests for lung cancer are now multivariate risk tests.2 These new risk tests incorpora...

    Show More
    Conflict of Interest:
    None declared.